Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.1000
0.00 (0.00%)
Jul 20, 2026, 2:12 PM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 28.41 million as of July 21, 2026. Its market cap has increased by 266.59% in one year.
Market Cap
28.41M
Enterprise Value
25.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
ChartMarket Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has increased from 17.41M to 28.41M, an increase of 63.16%. That is a compound annual growth rate of 7.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 28.41M | 134.27% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onco-Innovations | 38.72M |
| Sona Nanotech | 36.03M |
| Resverlogix | 34.38M |
| Telescope Innovations | 33.94M |
| Medicenna Therapeutics | 32.31M |
| Defence Therapeutics | 29.94M |
| Thiogenesis Therapeutics | 28.51M |
| Sharp Therapeutics | 27.37M |